Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Laureate Education Inc is an education & training services business based in the US. Laureate Education shares (LAUR) are listed on the NASDAQ and all prices are listed in US Dollars. Laureate Education employs 13,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$17.30|
|52-week range||$11.79 - $19.02|
|50-day moving average||$16.80|
|200-day moving average||$14.99|
|Wall St. target price||$19.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.96|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-0.57%|
|1 month (2021-09-17)||-1.09%|
|3 months (2021-07-16)||19.48%|
|6 months (2021-04-16)||28.91%|
|1 year (2020-10-16)||27.30%|
|2 years (2019-10-16)||10.97%|
|3 years (2018-10-16)||9.56%|
|5 years (2016-10-13)||N/A|
Valuing Laureate Education stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Laureate Education's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Laureate Education's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1465. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Laureate Education's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Laureate Education's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $248.8 million.
The EBITDA is a measure of a Laureate Education's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||14.63%|
|Gross profit TTM||$427 million|
|Return on assets TTM||2%|
|Return on equity TTM||-34.84%|
|Market capitalisation||$3.3 billion|
TTM: trailing 12 months
There are currently 3.8 million Laureate Education shares held short by investors – that's known as Laureate Education's "short interest". This figure is 8.4% down from 4.1 million last month.
There are a few different ways that this level of interest in shorting Laureate Education shares can be evaluated.
Laureate Education's "short interest ratio" (SIR) is the quantity of Laureate Education shares currently shorted divided by the average quantity of Laureate Education shares traded daily (recently around 670855.12367491). Laureate Education's SIR currently stands at 5.66. In other words for every 100,000 Laureate Education shares traded daily on the market, roughly 5660 shares are currently held short.
However Laureate Education's short interest can also be evaluated against the total number of Laureate Education shares, or, against the total number of tradable Laureate Education shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Laureate Education's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Laureate Education shares in existence, roughly 20 shares are currently held short) or 0.0392% of the tradable shares (for every 100,000 tradable Laureate Education shares, roughly 39 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Laureate Education.
Find out more about how you can short Laureate Education stock.
We're not expecting Laureate Education to pay a dividend over the next 12 months.
Over the last 12 months, Laureate Education's shares have ranged in value from as little as $11.79 up to $19.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Laureate Education's is 0.7522. This would suggest that Laureate Education's shares are less volatile than average (for this exchange).
Laureate Education, Inc. , together with its subsidiaries, provides higher education programs and services to students through a network of universities and higher education institutions. It offers a range of undergraduate and graduate degree programs primarily in the areas of business and management, medicine and health sciences, and engineering and information technology through campus-based, online, and hybrid programs. The company provides its services in Brazil, Mexico, Chile, Peru, and the United States. The company was formerly known as Sylvan Learning Systems, Inc. and changed its name to Laureate Education, Inc. in May 2004.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.